Prognostic and biological significance of survivin expression in patients with diffuse large B-cell lymphoma treated with rituximab-CHOP therapy

Prognostic and biological significance of survivin expression in patients with diffuse large B-cell lymphoma treated with rituximab-CHOP therapy Modern Pathology 28, 1297 (October 2015). doi:10.1038/modpathol.2015.94 Authors: Zhiyu Liu, Zijun Y Xu-Monette, Xin Cao, Ganiraju C Manyam, Xiaoxiao Wang, Alexandar Tzankov, Yi Xia, Xin Li, Carlo Visco, Ruifang Sun, Li Zhang, Santiago Montes-Moreno, Karen Dybkær, April Chiu, Attilio Orazi, Youli Zu, Govind Bhagat, Kristy L Richards, Eric D Hsi, William WL Choi, J Han van Krieken, Jooryung Huh, Maurilio Ponzoni, Andrés JM Ferreri, Ben M Parsons, Michael B Møller, Miguel A Piris, Jane N Winter, Dennis P O'Malley, L Jeffrey Medeiros & Ken H Young
Source: Modern Pathology - Category: Pathology Authors: Source Type: research
More News: Lymphoma | Pathology | Rituxan